JESSICA KNIGHT: Open Payments
NPI 1477039105 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 30 payments from 20 companies in 2025. Trend: 2023 $790 · 2024 $746 · 2025 $751
Food & beverage: $701Education: $50
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $152 |
| Daiichi Sankyo Inc. | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| Gilead Sciences, Inc. | 1 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| JAZZ PHARMACEUTICALS INC. | 2 | $28 |
| PharmaEssentia USA Corporation | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
Products named: Jakafi, Enhertu, Trodelvy, OPDIVO, LUTATHERA, Onivyde, ZIIHERA, BESREMI.
Industry payments across AR — which companies pay providers there.
